Evidera (PPD) Acquires Medimix International

TriNetX Acquires Advera Health Analytics

January 21, 2022

Data & Analytics

TriNetX has acquired Advera Health Analytics, the developer of the Evidex pharmacovigilance platform, to integrate Advera’s drug safety software and datasets into its real-world data network. The deal aims to give life sciences clients real-time safety signal detection, validation, and investigation capabilities by combining Evidex with TriNetX’s federated clinical datasets.

United BioSource (UBC) Acquires Evidinno Outcomes Research

January 5, 2026

Healthcare Services

United BioSource LLC (UBC) has acquired Vancouver-based Evidinno Outcomes Research Inc., adding real-world evidence (RWE), epidemiology, evidence synthesis and HEOR capabilities to UBC's evidence-generation platform. Evidinno will operate as a wholly owned subsidiary of UBC; Fairmount Partners served as exclusive financial advisor to Evidinno.

OptimizeRx Acquires EvinceMed Specialty Drug Market Access Platform

March 15, 2022

Healthcare Services

OptimizeRx Corporation acquired the EvinceMed platform and related assets to integrate end-to-end automation for specialty pharmaceutical transactions into its point-of-care network. The purchase expands OptimizeRx’s capabilities for specialty drug prescribing, patient enrollment into manufacturer support programs, and point-of-dispense connectivity to improve patient access and accelerate time-to-therapy.

Veranex Acquires Medidee to Expand European MedTech Capabilities

September 20, 2022

Healthcare Services

Veranex has acquired Medidee, a Lausanne-based MedTech regulatory and clinical consultancy, expanding Veranex's footprint and capabilities across Europe, India and APAC. The deal strengthens Veranex’s regulatory affairs, clinical development, and quality assurance services for medical device and in vitro diagnostic clients; financial terms were not disclosed.

Evident Acquires Pramana, Inc.

November 7, 2025

Medical Devices

Evident has completed its acquisition of Pramana, Inc., a Cambridge-based developer of autonomous whole slide imaging systems for digital pathology. The deal brings Pramana's AI-powered imaging and workflow technology into Evident's microscopy and optical-imaging portfolio to accelerate digital pathology capabilities and broaden solutions for hospitals, research institutions, and laboratories.

Thermo Fisher Scientific Acquires CorEvitas from Audax Private Equity

July 6, 2023

Data & Analytics

Thermo Fisher Scientific agreed to acquire CorEvitas, a Waltham, Massachusetts–based real-world evidence (RWE) and clinical registries provider, from Audax Private Equity for $912.5 million in cash. The acquisition, completed August 14, 2023, will fold CorEvitas (approximately 300 employees; expected 2023 revenue ~$110M) into Thermo Fisher’s Laboratory Products and Biopharma Services segment to expand its RWE and life‑sciences data capabilities.